UBQLN2, which is known to be involved in the degradation of misfolded proteins through the ubiquitin‒proteasome system, is downregulated in AD and other neurodegenerative disorders, and mutations in this gene have been linked to ALS [76, 77]. The gene discussed is UBQLN2; the disease is Alzheimer disease.